Entering text into the input field will update the search result below

Medtronic inks cross license deal with Tandem Diabetes Care

Jul. 09, 2020 9:29 AM ETMedtronic plc (MDT) Stock, TNDM StockBy: Douglas W. House, SA News Editor2 Comments
  • Aimed at avoid future legal spats over diabetes technology-related intellectual property, Medtronic (NYSE:MDT) and Tandem Diabetes Care (NASDAQ:TNDM) had executed a five-year cross-license agreement covering their respective patent portfolios in diabetes. The contract includes a provision not to clone each other's products.
  • No payment were exchanged in the matter. Further terms remain confidential.
  • Both stocks are up a fraction premarket.

Recommended For You

Related Stocks

SymbolLast Price% Chg
MDT
--
TNDM
--